NewsAwareness
What Stand Up To Cancer's MLB Placard Moments Actually Fund
Stand Up To Cancer's on-field baseball campaigns turn stadium moments into research dollars. Here's what the organization actually does with the money.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
The campaign
Have you watched a Major League Baseball broadcast lately? You may have seen fans and players hold up placards with the names of people affected by cancer. These "Placard Moments" come from a long-running partnership. It's between MLB and Stand Up To Cancer (SU2C). SU2C is a 501(c)(3) charity that raises money for cancer research. The moments appear during select nationally televised games, including World Series broadcasts. Minor League Baseball runs similar placard segments during its own season.
SU2C was founded to "raise awareness and fund research to detect and treat cancers with the aspiration to cure all patients." Its stated long-term goals include making early-stage detection standard practice. It also aims to reduce cancer deaths through funded research. The organization is not a hospital, a treatment provider, or a government agency. It's a fundraising and grant-making nonprofit. It channels donations toward outside scientists and institutions.
The baseball placard segments are one of several awareness efforts SU2C runs through the media. The organization has used similar moments in other broadcast partnerships over the years. Each pairs a personal detail — a name, a relationship — with a call to donate. Or it's simply a nudge to notice how common a cancer diagnosis is in a family. The on-field moment itself raises no money directly. Its purpose is visibility and reach. Donation appeals are typically directed to SU2C's own channels, not to MLB or any team.
What the money funds
By SU2C's own accounting, the organization has funded several hundred clinical trials. These trials involve tens of thousands of patients. It supports research through more than 3,100 researchers. They work across upward of 210 collaborating institutions. (SU2C's published trial and patient counts change as the organization updates them. Readers who want the current figure should check SU2C's own "Our Impact" page. Don't treat any single number here as fixed.) SU2C doesn't run its own labs. Instead, it typically funds "Dream Teams." These are groups of researchers from different institutions. They're asked to work together on one specific cancer problem. The organization says this approach speeds up translational research. That means turning lab discoveries into treatments that can be tested in patients.
Grant money pays for unglamorous but essential costs. These include data coordination and stats work for multi-site clinical trials. They include early-phase trials that test safety before larger trials assess patient benefit. And they include researcher pay or lab costs, especially for younger investigators. SU2C also funds early detection and precision-therapy work. The organization holds BBB accreditation and a Candid Platinum transparency rating. It publishes financial statements for accountability.
Why research funding matters
Clinical trials test whether a new screening method, drug, or treatment approach actually works in people. They're costly and slow. The National Cancer Institute describes several kinds. Treatment trials test new therapies. Prevention trials test ways to lower risk. Screening trials aim at earlier detection. Supportive care trials focus on quality of life during treatment. Any of these can take years. They need funding well before there's a marketable product. That's part of why nonprofit and charity funding matters, alongside government and industry money. It can support early-stage or higher-risk research that might not otherwise attract investment.
Donation-funded research groups like SU2C are one piece of a much larger cancer research funding system. That system also includes the National Institutes of Health, drug and biotech companies, universities, and other cancer charities. No single donation or campaign accounts for a cure. Treatments that reach patients typically pass through years of trials, regulatory review, and further real-world study.
What to keep in perspective
- SU2C funds and coordinates research grants; it does not develop drugs, treat patients, or guarantee that any funded trial will lead to an approved therapy.
- Broadcast partnerships like MLB's placard moments are primarily awareness and visibility efforts — the moment itself doesn't move money, and viewers are directed to donate separately.
- Cancer research funding is cumulative and collaborative; a single organization's grants are one contribution among many public and private sources supporting any given advance.
Sources
- Stand Up To Cancer — official site
- Stand Up To Cancer — Wikipedia, MLB partnership and Placard Moments
- National Cancer Institute — What Are Clinical Trials?
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Cancer research fundraising campaigns. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.